Enfusion
Enfusion (now "Enfusion by Clearwater") provides a cloud-native, front-to-back investment management SaaS platform for hedge funds, asset managers, and institutional investors, integrating portfolio management, order execution, IBOR, risk analytics, and regulatory reporting. Acquired by Clearwater Analytics in April 2025.
- Company typePublic
- Founded2014
- HeadquartersChicago, United States
- Headcount501–1,000
- GTM typeB2B
- OfferingSoftware
What Enfusion does
Enfusion (now operating as "Enfusion by Clearwater" following its April 2025 acquisition) is a cloud-native SaaS provider of front-office investment management software serving institutional investors, hedge funds, asset managers, and asset owners. Founded in 1998 and headquartered in Chicago, the company built a unified portfolio management, order and execution management, risk analytics, IBOR, and regulatory reporting platform designed to replace fragmented, legacy on-premise investment management workflows with a single integrated environment.
The core technology stack combines proprietary front-office modules — including the Investment Book of Record (IBOR), Portfolio & Order Management, Portfolio Workbench, and Risk & Performance capabilities — with middle- and back-office solutions integrated through Clearwater Analytics following the $1.5 billion acquisition. The combined platform processes over $10 trillion in assets with embedded AI capabilities: 1,000+ autonomous agents automating reconciliation, reporting, accounting, and compliance workflows, supported by Clearwater AI's generative AI layer (C1) and natural-language report generation. Enfusion historically operated a subscription-based SaaS revenue model with annual contracts ranging from approximately $100K to $5M, distributed through direct enterprise field sales and strategic channel partnerships including Northern Trust.
Enfusion generated $201.6 million in 2024 revenue (15.5% year-over-year growth) with ARR of $210.4 million and 103% net dollar retention across 916 institutional clients. The client base spans asset management (OfiInvest, Payden & Rygel, Chandler Asset Management) and insurance (PartnerRe, China Taiping Insurance), with geographic mix of 54% Americas, 27% APAC, and 19% EMEA and dedicated sales offices in New York, Hong Kong, and Singapore. Post-acquisition, Enfusion contributes the front-office layer to Clearwater Analytics' broader product suite, which adds Beacon (cross-asset trading and risk), Compass (investment intelligence), and the broader Clearwater AI platform serving 2,400+ global clients.
Enfusion firmographics
Firmographics- Name
- Enfusion
- Legal name
- Enfusion, Inc.
- Website
- https://enfusion.com
- Company type
- Public
- Founded year
- 2014
- Operating status
- Acquired
- Headcount range
- 501–1,000 employees
- Short description
- Enfusion (now "Enfusion by Clearwater") provides a cloud-native, front-to-back investment management SaaS platform for hedge funds, asset managers, and institutional investors, integrating portfolio management, order execution, IBOR, risk analytics, and regulatory reporting. Acquired by Clearwater Analytics in April 2025.
- Ownership category
- akta.pro rank
Enfusion industry classification
Industry- Product category
- Investment Management Software
- NAICS
- Portfolio Management and Investment Advice (523940), Portfolio Management and Investment Advice (52394)
- SIC
- Services-Prepackaged Software (7372), Services-Computer Integrated Systems Design (7373), Investment Advice (6282)
- akta.pro primary industry
- Portfolio Construction & Asset Allocation Advisory (FSAEAAAC)
- akta.pro secondary industries
- iPaaS / Cloud Data Integration (HDAEACAD), iPaaS (Cloud Integration Platforms) (HDAEAIAB)
Keywords
Where Enfusion is headquartered
LocationHeadquarters
- HQ city
- Chicago
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Enfusion business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations
Revenue model
- Subscription-based SaaS Revenue: Enfusion operates as a SaaS provider generating recurring subscription revenue from its cloud-native investment management platform. The company reported 2024 total revenue of $201.6 million with Annual Recurring Revenue of $210.4 million as of December 2024. Net dollar retention rate stood at 103.0% as of December 2024.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise pricing typically ranges from $100K-$5M depending on firm size |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels3 records
Enfusion product offering
Product offeringCore offering
Enfusion provides a cloud-native, unified front-to-back investment management SaaS platform that combines portfolio management, order and execution management, risk analytics, and accounting/reporting for institutional investors, hedge funds, and asset managers. Following its April 2025 acquisition by Clearwater Analytics, the offering now operates as 'Enfusion by Clearwater', integrating front-office capabilities with middle and back-office solutions to streamline the full investment lifecycle.
Product overview
Enfusion, acquired by Clearwater Analytics in April 2025 for approximately $1.5 billion, operates as a cloud-native investment management SaaS platform now branded as 'Enfusion by Clearwater'. The platform provides a unified front-to-back investment management environment for asset managers, hedge funds, and institutional investors, integrating portfolio management, order execution, and trading capabilities. The broader Clearwater platform processes over $10 trillion in assets and serves 2,400+ global clients. Key products include Enfusion by Clearwater (unified portfolio management and order execution), Beacon by Clearwater (cross-asset trading and risk analytics), and Clearwater Compass (investment intelligence). Supporting modules cover Investment Book of Record, Portfolio & Order Management, Risk & Performance, Accounting & Reporting, Pre- & Post-Trade Compliance, and Regulatory Compliance. Clearwater AI is embedded throughout the platform as an AI-driven workflow layer.
Differentiator
Problem solved
Functional benefit
Products and services
- Enfusion by Clearwater A front-to-back environment that streamlines portfolio management, trading, and execution for institutional investors and asset managers, enabling seamless transition from investment decisions to action.
- Beacon by Clearwater Cross-asset trading and risk management solution providing AI-powered analytics and modeling tools for testing scenarios, evaluating exposures, and understanding portfolio behavior in real time.
- Clearwater Compass
Quantifiable outcome
- 103% net dollar retention rate
- +2 more outcomes
Companies that use Enfusion
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles4 records
Enfusion technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability8 records
Feature3 records
Enfusion partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core, supporting and flagship.
- Northern TrustcoreNorthern Trust established a strategic alliance with Enfusion to provide integrated portfolio management, order and execution management, and analytics capabilities to mutual clients. The collaboration enables asset managers, hedge funds, and asset owners to access a unified cloud-native platform combining Northern Trust's asset servicing with Enfusion's SaaS infrastructure. The alliance includes a co-developed certified interface with Equity Data Science and is part of Northern Trust's Whole Office strategy for end-to-end solutions across the investment lifecycle.
- Equity Data SciencesupportingCo-developed certified interface with Equity Data Science as part of the Northern Trust-Enfusion strategic alliance, enabling enhanced analytics capabilities for mutual clients.
- Clearwater AnalyticsflagshipClearwater Analytics acquired Enfusion for approximately $1.5 billion (enterprise value), integrating Enfusion's front-office capabilities with Clearwater's middle and back-office solutions to create a unified cloud-native front-to-back platform for institutional investors. The acquisition expanded Clearwater's total addressable market by $1.9 billion and is expected to deliver approximately $20 million in cost synergies.
Scale indicators7 records
Recent moves6 records
Expansion highlights5 records
Enfusion competitors and assessment
Company assessmentBroad incumbents
- BlackRock Aladdin: BlackRock's Aladdin is the dominant institutional investment management platform combining portfolio management, risk analytics, trading, and operations. It competes head-to-head with Enfusion's unified front-to-back offering at large enterprise asset managers and insurers.
- Bloomberg AIM: Bloomberg's Asset & Investment Manager (AIM) platform offers order management, portfolio tracking, and analytics to buy-side firms. While part of Bloomberg's broader Terminal ecosystem, it directly competes for the same institutional asset manager and hedge fund clients.
- Finastra: Finastra provides capital markets and investment management technology across front, middle, and back office. While broader than Enfusion's niche, it competes for institutional asset manager platform modernization budgets.
Direct peers
- State Street Charles River Development: Charles River provides order management, portfolio management, and compliance tools for institutional asset managers and hedge funds. It is one of the closest direct competitors to Enfusion's IBOR and front-office investment management capabilities.
- SS&C Advent: SS&C's Advent platform (Axiom, Geneva, Moxy) provides portfolio management, order management, and accounting for hedge funds and asset managers — directly overlapping Enfusion's core customer base and product functionality.
- SimCorp: SimCorp Dimension is an integrated investment management platform serving buy-side institutions with portfolio management, compliance, and analytics — a direct competitor in the institutional asset management segment where Enfusion operates.
- Eze Software (SS&C Eze): Eze provides front-to-back investment management software including order management, execution, and portfolio analytics for hedge funds and asset managers — closely aligned with Enfusion's core offering and target customer base.
Emerging players
- Canoe Intelligence: Canoe Intelligence uses AI to automate alternative investment document processing and data extraction for institutional investors. It overlaps with Enfusion's alternatives-focused workflows and Clearwater's broader alternative asset data strategy.
- Orion Advisor Solutions: Orion provides portfolio accounting, performance reporting, and trading technology to wealth managers and asset managers. While more wealth-management-focused, it competes for adjacent institutional platform spend and modernization budgets.
Others
- Northern Trust Whole Office: Northern Trust's Whole Office strategy combines its asset servicing capabilities with partner platforms (including Enfusion) to deliver integrated front-to-back investment solutions. As a strategic partner and competitor-adjacent platform, it shapes Enfusion's go-to-market motion.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Enfusion social profiles
Digital presenceEnfusion financial estimates
Financial estimateRevenue estimate
Valuation estimate
Enfusion leadership team
Management profileNumber of profiles
Profiles9 records
Enfusion funding detail
Funding detailFunding overview
Funding rounds4 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Enfusion M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Enfusion
What does Enfusion do?
Enfusion provides a cloud-native, unified front-to-back investment management SaaS platform that combines portfolio management, order and execution management, risk analytics, and accounting/reporting for institutional investors, hedge funds, and asset managers. Following its April 2025 acquisition by Clearwater Analytics, the offering now operates as 'Enfusion by Clearwater', integrating front-office capabilities with middle and back-office solutions to streamline the full investment lifecycle.
Is Enfusion a public or private company?
Enfusion is a public company. It is classified as corporate owned and is currently acquired.
When was Enfusion founded?
Enfusion was founded in 2014. It employs 501 to 1,000 people.
Where is Enfusion based?
Enfusion is headquartered in Chicago, United States, in the North America region.
How does Enfusion make money?
One revenue line is on record: subscription-based SaaS Revenue.
Who are Enfusion's main competitors?
Broad incumbents on record are BlackRock Aladdin, Bloomberg AIM and Finastra. Direct peers are State Street Charles River Development, SS&C Advent, SimCorp and Eze Software (SS&C Eze). Emerging players are Canoe Intelligence and Orion Advisor Solutions. Northern Trust Whole Office is listed as an others.
Does Enfusion have an API?
No public API is recorded for Enfusion.
What industry is Enfusion in?
Enfusion's product category is Investment Management Software. Its primary akta.pro industry code is FSAEAAAC, Portfolio Construction & Asset Allocation Advisory, with a secondary code of HDAEACAD, iPaaS / Cloud Data Integration. Its NAICS code is 523940 and its SIC code is 7372.